Wondering if Teva Pharmaceutical Industries is now a bargain or if you might be late to the party? You're not alone. Investors are searching for value in a market where expectations are shifting fast.

The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone. Along ...

Teva Pharmaceutical says it has reached an agreement in principle to settle thousands of lawsuits accusing it of fuelling the opioid crisis in the US for up to $4.25 billion, including already settled ...

To get a sense of who is truly in control of Teva Pharmaceutical Industries Limited (NYSE:TEVA), it is important to understand the ownership structure of the business. We can see that institutions own ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.